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Aliphatic iV-nitrosomethylalkylamines exhibit a remarkable
organ specificity in rats, the principal targets for tumour in-
duction being liver, oesophagus, urinary bladder and lung.
We have determined the extent of DNA methylation in these
tissues following a single oral dose (0.1 mmol/kg; 6 h sur-
vival) of each of 12 homologues, ranging from N-nitro-
sodimethyiamlne (Cl) to A4utrosomethyldodecylamine (C12).
Methylpurines (7- and O*-methylguanine) were determined
by cation exchange HPLC with fluorescence detection.
Highest levels of hepatic DNA methylation were found with
A'-nkrosodimethjiainine (Cl) and A'-nitrosornethylethylamine
(C2), the most potent bepatocarcinogens in this series. Con-
centrations of methylpurines in liver DNA decreased with in-
creasing chain length for C1-C5. Administration of the
higher homologues (C6-C12) caused levels of DNA methyla-
tion which by themselves were considered too low to account
for their hepatocarcinogenicity. In rat oesophagus, DNA
methylation closely paralleled carcinogenkity, the butyl and
pentyl derivatives (C4, C5) being most effective. In rat lung,
the extent of DNA methylation was generally lower and there
was no apparent correlation with carcinogenicity. Methyla-
tion of kidney DNA also decreased with increasing chain
length and was only detectable for C1-C5. In urinary blad-
der DNA, methylpurines were below or close to the limit of
detection. It is concluded that the initiation of malignant
transformation by DNA methylation alone (through hydrox-
ylation at the methylene a-carbon) could be operative for Cl
in kidney and lung, for Cl and C2 in liver, and C3-C5 in
oesophagus. For the higher homologues, the extent of DNA
methylation seems insufficient to explain the complex pattern
of tissue specificity, suggesting that DNA modification other
than, or in addition to, methylation may be responsible.
Introduction
Early investigations by Druckrey and co-workers (1) on the
carcinogenicity of asymmetric nitrosamines in rats revealed a
high degree of organ-specificity. Short-chain N-nitrosomethyl-
alkylamines (Cl, C2*) induced predominantly rumours of liver
and lung whereas the higher asymmetric homologues (C3-C6)
produced exclusively or preferentially oesophageal neoplasms.
•Abbreviations: A'-Nrtrosornethylalkylamines were designated according to the
length of the alkyl chain opposite the methyl moiety, i.e. Cl (W-nitrosodimethyl-
amine) to C12 (JV-nitrosomethyldodecylamine).
Subsequent work by Lijinsky and co-workers on A/-nitrosomethyl-
alkylamines containing an alkyl group with more than five car-
bon atoms showed a striking alternating pattern, with nitrosamines
containing an even-numbered carbon chain (C8, CIO, C12) pro-
ducing urinary bladder tumours and those with an odd-numbered
carbon chain (C7, C9, Cl 1) inducing liver and lung tumours
(2,3). Investigations into the biological basis of this correlation
between chemical structure and organ-specific carcinogenicity
(Figure 1) have in the past focused on AZ-nitrosomethylbenzyl-
amine (4), A/-nitrosomethylethylamine (5) and JV-nitrosomethyl-
pentylamine (6), and have led to the assumption that the induction
of oesophageal carcinomas is related to a preferential bioactiva-
tion of these nitrosamines by a P-450 isozyme in die oesophageal
mucosa with high substrate specificity for asymmetric
nitrosamines (4,5,7). In addition, mere was evidence that the
adverse biological effects of these agents is mediated by a
mediylation of cellular macromolecules. DNA modifications
resulting from an initial hydroxylation of the methyl group were
either not detectable (benzylation) or occurred at a considerably
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Fig. 1. Maximum reported tumour incidence in various tissues of male rats
exposed to /V-nitrosomethylalkylamines ranging from JV-nitrosodimethylamine
(Cl) to /V-nitrosomethyldodecylamine (C12). Carcinogens were given twice
weekly by gavage at a dose of 0.014 (C3), 0.021 (C4), 0.025 (Cl, C2),
0.04 (C6), 0.05 (C12) and 0.11 (C7-C11) mmol/kg. JV-Nitrosomethylpropyl-
amine (C3) and /V-nitrosomethylpentylamine (C5) were administered in the
drinking water at concentrations of 14 and 30 mg/1 respectively. Compounds
Cl - C 4 and C6-C12 were given to Fischer 344 rats, and C5 to nus of the
Donryu strain. Data were compiled from refs (3,6,10,28).
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lower extent (ethylation, hydroxyethylation) than did DNA
methylation. This prompted us to determine the extent of DNA
methylation in target and non target rat tissues produced by an
equimolar dose of homologous A'-nitrosomethylalkylamines,
ranging from N-iiitrosodimethylamine (Cl) to A'-nitrosomethyl-
dodecylamine (C12). The study was designed to elucidate the
structural requirements for bioactivation leading to DNA methyla-
tion and to correlate this with the results of long-term car-
cinogenicity studies.
Materials and methods
Chemicals
Nitrosamines were prepared as described previously (2,8 — 10). All nitrosamines
were found to be pure and authentic as judged by n.m.r. spectroscopy. The samples
were also checked by h.p.l.c. on RP-18 columns (Shandon, ODS Hypersil,
4.6 x 250 mm) with u.v.-detection at 230 nm. Using isocratic methanol/water
eluents as mobile phase (10—85% methanol, depending on the hydrophobicity
of the homologue), all samples eluted as a major peak followed by a smaller
second peak representing the respective z-isomer.
Animals and treatment
Young male Fischer 344 rats (120 — 150 g body wt) were obtained from Charles
River Wiga GmbH (FRG) and maintained on a standard laboratory diet with water
ad libitum. Nitrosamines were dissolved in sterile-filtered tap water containing
0.25% Cremophor EL sdubilizer (Sigma, St. Louis, MO) and subjected to mild
bath sonican'on prior to use. Carcinogens were administered by gavage in a volume
of 1 ml/100 g body wt.
The time course of formation and persistence of 7-methylguanine in hepatic
DNA was determined in groups of two animals receiving a single dose of 0.1
mmol/kg of C3, C6 or C12. Survival times were 3, 6, 9 and 12 h. In a further
experiment, groups of 10 animals received a single dose of 0.1 mmol/lcg of each
nhrosamine of the series from C1 to C12 and were killed 6 h later. Tissues were
rapidly removed, frozen in liquid nitrogen and stored at -70°C until analysis.
DNA isolation and analysis of adducts
DNA was isolated by phenolic extraction and adsorption onto hydroxylapatite
as previously described (5). Following mild acid hydrolysis (0.1 M HC1 at 37°C
for 20 h), the amounts of 7-methylguanine and O^-methylguanine were deter-
mined by h.p.l.c. using a modification of the procedure of Swenberg and Bedell
(11), as previously described (12). Briefly, purine bases were separated on a strong
cation exchange column (Partisil SCX, 0.46 x 250 mm), eluted at 2 ml/min with
-50 mM N H ^ P O * , pH 2 (7-methylguanine), or with the same buffer contain-
ing 10% (vol/vol) methanol (C^-methylguanine). Under these conditions,
7-methylguanine eluted at 9.5 min and O^-methylguanine at 8.7 min. Quantifica-
tion of methylpurines was carried out with a Shimadzu spectrofluorophotometer
(RF-540), set at 295 nm for excitation and 370 nm for emission. Calibration of
the fluorescence signal was performed by injecting radiolabelled methylpurines
and determining both radioactivity and fluorescence.
Since the amount of DNA obtained from most tissues was too small to allow
for individual analyses, organs from 10 animals were pooled before DNA isola-
tion. Duplicate or triplicate analyses were carried out whenever possible and were
usually found to differ by less than 10%.
Results
To estimate the most suitable survival time, i.e. when >90%
of the nitrosamine would be metabolized, the time course of
methylpurine formation in hepatic DNA was determined for some
representative A^-nitrosomethylalkylamines (C3, C6 and C12).
Concentrations of 7-methylguanine produced in hepatic DNA by
a single oral dose (0.1 mmol/kg) were highest between 3 —6 h.
At longer time intervals, up to 12 h, there was no significant
change in the amout of 7-methylguanine (Figure 2). It was,
therefore, decided that 6 h would be an appropriate time inter-
val for determining the extent of DNA methylation by a large
series of N-nitrosomethylalkylamines. The results of the latter
experiment, in which groups of 10 rats received a single oral
dose of 0.1 mmol/kg, are shown in Figure 3. The greatest ex-
tent of DNA methylation was observed in liver following ad-
ministration of Cl, with 7-methylguanine and C^-methylguanine
concentrations amounting to 3290 and 330 /imol/mol guanine
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Fig. 2. Concentration of 7-methylguanine in hepatic DNA of male Fischer
344 rats at different time intervals following a single oral dose (0.1 mmolAg)
of N-nitrosomethylpropylamine (C3), Af-nitrosomethylhexylamine (C6) and
A'-nitrosomethyldodecylamine (C12). Data from pooled livers of three
animals for 3, 9 and 12 h and from 10 animals for 6 h. G, guanine.
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Fig. 3. DNA methylation in liver, oesophagus, lung and kidney of male
F344 rats following a single oral dose (0.1 mmol/kg each) of homologous
A'-nitrosomethylalkylamines ranging from A/-nitrosodimethylamine (Cl) to
A<-nitrosomethyldodccylamine (C12). Concentrations of 7-methylguanine
(open columns) and (Amethylguanine (filled columns) are expressed as
fimol/mol guanine.
respectively. Hepatic DNA methylation decreased with increas-
ing length of the alkyl chain, the lowest value being observed
for A'-nitrosomethyldodecylamine (C12). The amount of
7-methylguanine produced by C12 comprised only 5% of that
produced by an equimolar dose of N-nitrosodimethylamine (Cl).
Long-chain /V-nitrosomethylalkylamines (C6-C12) all produc-
ed a low extent of hepatic DNA methylation (200-600 /imol
7-methylguanine/mol guanine).
In contrast, concentrations of 7-methylguanine in oesophageal
DNA increased from values below the level of detection (Cl and
C2) to 800 and 370 /unol 7-methylguanine/mol guanine for N-
nitrosomethylbutyl- and -methylpentylamine, respectively. On-
ly with C4 was the extent of methylation in the oesophagus higher
than in liver. Following administration of long chain homologues
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(C6-C12), 7-methylguanine was not found in oesophagus. The
detection limit for C^-methylguanine was somewhat lower due
to its strong fluorescence, and traces of this promutagenic base
(< 5 /*mol/mol guanine) in oesophagus were detectable with all
compounds with the exception of C2. The highest level of
pulmonary DNA methylation (190 /tmol 7-methylguanine/mol
guanine) was found after administration of /V-nitrosodimethyl-
amine (Cl), but this was still 15 times lower than in rat liver.
7-Methylguanine concentrations in lung ranging from 30 to 100
/tmol/mol guanine were found with C2-C5 and C10-C12,
whereas equimolar doses of C6 - C9 only produced trace amounts
of C^-methylguanine (<2 /imol/mol guanine). In kidney DNA,
methylpurines were only detectable after administration of
Cl — C4. As observed in rat liver, there was a tendency for a
decrease in alkylation with increasing chain length. In the urinary
bladder, trace amounts of O^-methylguanine were detectable
after administration of C6, C9, CIO (<2 /imol/mol guanine) and
C12 ( < 5 /tmol/mol guanine).
Discussion
Carcinogenic A -^nitroso compounds are characterized by their
capacity to selectively induce a high incidence of malignant
tumours in a wide spectrum of target tissues (1,3,13). The
biological basis of organ-specific carcinogenesis is not yet fully
understood, but several factors have been implicated; including
distribution of the parent carcinogen, tissue- and cell-specific
bioactivation, cell turnover and DNA repair (for review see refs
14—20). The objective of the present study was to determine
the extent to which aliphatic /V-nitrosomethylalkylamines
methylate cellular DNA in various rat tissues. Since car-
cinogenicity data are available for all of these compounds, it was
possible to correlate organ specific tumour induction with levels
of methylation in target and non target tissues. We realize that
for each tissue, the extent of DNA modification resulting from
chronic exposure may differ significantly from that found in single
dose experiments, mainly due to different rates of cell turnover
and DNA repair. It is also evident that enzymic metabolism of
A^-nitrosomethylalkylamines is very complex and generation of
a methylating intermediate is only one of several possible end-
points of bioactivation. However, we feel that despite these limita-
tions, the results allow some tentative conclusions and hypotheses
which may be further tested in a more comprehensive study of
DNA modifications resulting from exposure to long-chain asym-
metric nitrosamines.
DNA methylation is most likely to result from a single hydrox-
ylation step at the a-C position of the alkyl chain opposite the
methyl moiety. Metabolism can occur at other carbon atoms prior
to conversion to a methylating agent but the more polar in-
termediates so formed are stable and often more easily excreted
than the parent nitrosamine. It is most probable that the pathway
for the production of methyl adducts is initial alkyl a-C hydrox-
ylation, since the resulting intermediate is very short-lived and
will react rapidly with available nucleophiles. Following incuba-
tion of rat oesophagus with N-nitrosomethylpentylamine (C5) in
vitro, Mirvish et al. (7) identified four hydroxy derivates, but
only those resulting from attack at C-atoms 2—5. It was con-
cluded that the a-hydroxy intermediate was too short-lived for
chemical detection. This view is also supported by recent studies
on /V-nitrosomethylethylamine (C2) in our laboratory. Although
there was evidence of extensive hydroxylation at the /3-carbon
of the ethyl group, this led to only a very small amount of DNA
hydroxyethylation (5). Accordingly, one would expect a high ex-
tent of methylation only with those A'-nitrosomethylalkylamines
which are exclusively or predominantely bioactivated by initial
a-C hydroxylation at the alkyl group opposite the methyl moie-
ty. The results shown in Figure 3 suggest that this occurs for
Cl and C2 in rat liver, and for C4 and C5 in the oesophagus.
For the homologous series from /V-nitrosodimethylamine to N-
nitrosomethylpentylamine (C1-C5), DNA methylation in rat
liver was found to decrease with increasing length of the alkyl
chain (Figure 3). The generally low levels of methylation pro-
duced by C5 -C12 indicate that the liver does not possess P-450
isozymes capable of efficiendy a-hydroxylating nitrosomethyl-
alkylamines with chain lengths greater than four.
Comparing the present results widi those of long-term car-
cinogenicity studies, we conclude that initiation of hepato-
carcinogenesis by DNA mediylation alone can only be assumed
for nitrosodimethylamine (Cl). With A'-nitrosomethylethylamine
(C2), methylation is by far the primary type of adduct formed
(5,21), but ethylation has also been shown to occur, although
at levels four times less than would be expected if this compound
acted as a true hybrid between Cl and N-nitrosodiethylamine (12).
The possibility must be considered that methylation may func-
tion to saturate the C^-alkylguanine-DNA alkyltransferase and
thereby potentiate the effects of more minor adducts. Both Cl
and C2 are strong hepatocarcinogens and produced 7-methyl-
guanine and C^-methylguanine concentrations of more than
2000 and 200 /imol/mol guanine/0.1 mmol nitrosamine/kg
respectively. /V-Nitrosomethylpropylamine (C3) produced less
than 100 /imol C^-methylguanine/mol guanine at this dose and
is not known to induce liver cancer in rats. All higher homologues
(C4—C12) caused substantially less DNA methylation than does
C3, although several of these (C6-C9 and Cl 1) induce a high
incidence of hepatic carcinomas following chronic oral ad-
ministration. This would suggest that the initiation of liver car-
cinogenesis by these agents requires DNA modifications other
than, or in addition to, methylation.
In their pioneering work on the structure-activity relation-
ships of carcinogenic nitroso compounds, Druckrey and co-
workers (1) established that the most powerful oesophageal car-
cinogens are asymmetric dialkylnitrosamines with a methyl group
as one of the alkyl moieties. The present study on the complete
series of 12 homologous aliphatic methylalkylnitrosamines of-
fers closer insight into the structural requirements for oesophageal
tumour induction. Methylation of oesophageal DNA by nitro-
sodimethylamine was below the level of quantitative detection
and this corresponds with the observation that this agent has never
produced tumours in this organ, irrespective of dose and route
of administration (1,22). While the next higher homologue (C2)
produced very low levels of alkylation in rat oesophagus, previous
radiochromatographic analyses established that following a single
i.p. or p.o. dose, concentrations of 7-methylguanine in rat liver
are 100 times higher than in the oesophagus (5). Nevertheless,
N-nitrosomethylethylamine does produce a low incidence of
oesophageal carcinomas in addition to hepatic neoplasms when
administered in the drinking water (9). The present data (Figure
3) show a considerable extent of oesophageal DNA methylation
(7-methylguanine/guanine) by the next higher homologues, with
oesophagus/liver ratios increasing from 0.069 (C3) to 1.28 (C4)
and 0.98 (C5). These three compounds are powerful oesophageal
carcinogens, producing highly malignant squamous carcinomas
after an induction time of only 4—6 months (3,6,10). The other
compounds studied produce neither oesophageal tumours nor ex-
tensive oesophageal DNA methylation, except for A/-nitroso-
methylhexylamine (C6) which is a fairly potent carcinogen in
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this organ (10) even though its capacity to methylate target organ
DNA was found to be low (Figure 3). In conclusion, the present
study shows that (with the exception of C6) DNA methylation
in rat oesophagus closely parallels carcinogenicity. In conjunc-
tion with earlier studies (4,7,23,24), this suggests that the
oesophageal mucosa of rats contains a P-450 isozyme capable
of metabolizing asymmetric nitrosamines at the a-methylene posi-
tion, with highest substrate specificities for those with a chain
length of 3—5 C-atoms. Our data also reveal that the amount
of DNA methylation required to initiate liver carcinogenesis is
considerably higher than that required to produce a similar in-
cidence of oesophageal cancer. The results obtained suggest that
any agent which in rat oesophagus produces 2r 10 /imol
Cr-methylguanine/mol guanine/0.1 mmol nitrosamine/kg is a
strong and often selective oesophageal carcinogen, i.e. at levels
10—20 times lower than observed in liver DNA following ad-
ministration of an equimolar dose of a potent hepatocarcinogen.
Lung tumours are induced by long-term exposure to N-
nitrosomethylalkylamines at incidences ranging from 30 to 80%
(Figure 1), with the exception of C3-C5. The lack of pulmonary
response to the latter may be due to the fact that these agents
very rapidly produce fatal oesophageal carcinomas. The extent
of DNA methylation following a single exposure (Figure 3) was
generally low and there was no correlation with long-term car-
cinogenicity. In particular, no methylpurines were detectable after
administration of C6 —C8, i.e. compounds known to induce a
40—60% incidence of pulmonary neoplasms after chronic ex-
posure.
Kidney DNA, too, showed levels of DNA methylation ~ 15
times lower than in liver, but shares with the latter a tendency
for decreasing levels of methylpurines with increasing chain
length for Cl - C 4 . All higher homologues (C5-C12) failed to
produce detectable amounts of 7- and C^-methylguanine,* in-
dicating a lack of P-450 enzymes capable of a-C hydroxylation
if the number of C-atoms exceeds four. In carcinogenicity studies
employing administration by gavage (C2 and C4) and in drink-
ing water (Cl— C5), kidney tumours were not reported. The
reason for this discrepancy is not known but there seems to be
a general tendency for rat kidney to undergo malignant transfor-
mation following pulsed doses rather than chronic exposure in
drinking water (25).
The present data on DNA methylation do not explain the in-
duction of liver and urinary bladder carcinomas by long-chain
odd- and even-numbered N-nitrosomethylalkylamines respective-
ly. We did detect small amounts (~5 junol/mol guanine) of
O*-methylguanine in bladder DNA following administration of
N-nitrosomethyldodecylamine (C12) and trace amounts after ex-
posure to C6, C9 and C10. Since this does not correlate with
the induction of bladder cancer by these agents, we assume that
adducts other than methylpurines are responsible and/or the levels
of methylation change after chronic administration. It is known,
however, that methylation alone is sufficient to transform blad-
der epithelium of rats (26). We agree with the hypothesis put
forward by Okada (27) that tissue specificity depending on even
or odd chain length can best be explained by the Knoop type
of /3-oxidation which, in the case of even-numbered AZ-nitroso-
methylalkylamines, would eventually yield TV-nitrosomethyl-
carboxypropylamine, a potent bladder carcinogen in rats. If
this were true, one would expect bladder tumours also after
administration of A/-nitrosornethylhexylamine and A/-nitroso-
methylbutylamine (C4), which should similarly be oxidized to
form A/-nitrosomethylcaiboxypropylamine. The low incidence of
bladder tumours produced by C6 (9) and the lack of a carcino-
genic response of this organ to C4 is probably due to the very
rapid and fatal induction of oesophageal carcinomas.
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